Peer Review reports
From: A novel inflammatory marker for extensive ulcerative colitis; Endocan
| Original Submission | ||
|---|---|---|
| 25 Sep 2022 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 31 Oct 2022 | Reviewed | Reviewer Report |
| 1 Feb 2023 | Reviewed | Reviewer Report - Ilhami Yüksel |
| 13 Feb 2023 | Author responded | Author comments - Bulent Albayrak |
| Resubmission - Version 4 | ||
| 13 Feb 2023 | Submitted | Manuscript version 4 |
| 15 Feb 2023 | Author responded | Author comments - Bulent Albayrak |
| Resubmission - Version 5 | ||
| 15 Feb 2023 | Submitted | Manuscript version 5 |
| 20 Feb 2023 | Author responded | Author comments - Bulent Albayrak |
| Resubmission - Version 6 | ||
| 20 Feb 2023 | Submitted | Manuscript version 6 |
| 24 Feb 2023 | Reviewed | Reviewer Report - Ilhami Yüksel |
| 11 Mar 2023 | Reviewed | Reviewer Report |
| Resubmission - Version 7 | ||
| Submitted | Manuscript version 7 | |
| Publishing | ||
| 13 Mar 2023 | Editorially accepted | |
| 11 Apr 2023 | Article published | 10.1186/s12876-023-02720-8 |
You can find further information about peer review here.